Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor
Open Access
- 1 December 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 113 (4), 1099-1104
- https://doi.org/10.1111/j.1476-5381.1994.tb17109.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Preservation of endothelium-dependent vasodilation in the spastic segment of the human epicardial coronary artery by substance PAmerican Heart Journal, 1992
- Cyclosporin treatment does not impair the release of nitric oxide in human coronary arteries.Heart, 1991
- THE EFFECT OF CYCLOSPORINE ON THE RELEASE OF ENDOTHELIUM-DERIVED RELAXING FACTOR FROM ISOLATED HUMAN EPICARDIAL CORONARY ARTERIESTransplantation, 1991
- Evidence That Contractions of Isolated Arteries by l-NMMA and NOLA Are Not Due to Inhibition of Basal EDRF ReleaseJournal of Cardiovascular Pharmacology, 1991
- Endothelium-derived relaxing factorPharmacology & Therapeutics, 1989
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Potent effects of neuropeptide Y and calcitonin gene‐related peptide on human coronary vascular gene in vitroActa Physiologica Scandinavica, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980